Unknown affiliation
Verified email at
Cited by
Cited by
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
J Garnacho-Montero, JL Garcia-Garmendia, A Barrero-Almodovar, ...
Critical care medicine 31 (12), 2742-2751, 2003
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain
R Ferrer, A Artigas, MM Levy, J Blanco, G Gonzalez-Diaz, ...
Jama 299 (19), 2294-2303, 2008
A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
C León, S Ruiz-Santana, P Saavedra, B Almirante, J Nolla-Salas, ...
Critical care medicine 34 (3), 730-737, 2006
Treatment of Multidrug-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem …
J Garnacho-Montero, C Ortiz-Leyba, FJ Jimenez-Jimenez, ...
Clinical Infectious Diseases 36 (9), 1111-1118, 2003
Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients
J Garnacho-Montero, J Madrazo-Osuna, JL Garcia-Garmendia, ...
Intensive care medicine 27 (8), 1288-1296, 2001
Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery
SR Leal-Noval, MD Rincón-Ferrari, A García-Curiel, A Herruzo-Avilés, ...
Chest 119 (5), 1461-1468, 2001
Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients
J Garnacho-Montero, R Amaya-Villar, JL García-Garmendía, ...
Critical care medicine 33 (2), 349-354, 2005
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
J Garnacho-Montero, A Gutiérrez-Pizarraya, A Escoresca-Ortega, ...
Intensive care medicine 40 (1), 32-40, 2014
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
J Garnacho-Montero, C Ortiz-Leyba, E Fernández-Hinojosa, ...
Intensive care medicine 31 (5), 649-655, 2005
Risk Factors for Acinetobacter baumannii Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study
JL García-Garmendia, C Ortiz-Leyba, J Garnacho-Montero, ...
Clinical infectious diseases 33 (7), 939-946, 2001
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy
J Garnacho-Montero, M Sa-Borges, J Sole-Violan, F Barcenilla, ...
Critical care medicine 35 (8), 1888-1895, 2007
Multiresistant Acinetobacter baumannii infections: epidemiology and management
J Garnacho-Montero, R Amaya-Villar
Current opinion in infectious diseases 23 (4), 332-339, 2010
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
I Martin-Loeches, T Lisboa, A Rodriguez, C Putensen, D Annane, ...
Intensive care medicine 36 (4), 612-620, 2010
Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome
J Garnacho-Montero, R Amaya-Villar, C Ortiz-Leyba, C León, ...
Critical Care 9 (3), R191, 2005
Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital
R Valencia, LA Arroyo, M Conde, JM Aldana, MJ Torres, ...
Infection control and hospital epidemiology 30 (3), 257, 2009
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain
M Puig-Asensio, B Padilla, J Garnacho-Montero, O Zaragoza, JM Aguado, ...
Clinical Microbiology and Infection 20 (4), O245-O254, 2014
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain
M Bassetti, M Merelli, E Righi, A Diaz-Martin, EM Rosello, R Luzzati, ...
Journal of clinical microbiology 51 (12), 4167-4172, 2013
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality
M Bassetti, E Righi, F Ansaldi, M Merelli, T Cecilia, G De Pascale, ...
Intensive care medicine 40 (6), 839-845, 2014
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study
J Garnacho-Montero, C Ortiz-Leyba, I Herrera-Melero, T Aldabo-Pallas, ...
Journal of Antimicrobial Chemotherapy 61 (2), 436-441, 2008
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
J Rodríguez-Baño, JR Paño-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ...
Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012
The system can't perform the operation now. Try again later.
Articles 1–20